Key Points Non-GAAP earnings per share and GAAP revenue both surpassed analyst estimates, with adjusted funds from operations (AFFO) also showing modest growth. Combined portfolio net operating income ...

Glucagon injection salesdeclined 25% to $20.6 million in Q2 2025, driven by increased competition and a market shift toward ...

Q2 2025 Management View Scott L. Thompson, Chairman, President and CEO, stated that "Somnigroup delivered another quarter of solid performance, driven by disciplined execution and progress in our ...

Eli Lilly stock beats Q2 estimates with strong sales but faces competitive risks and high valuation. Here's why investors may ...

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 62 cents per share. The electric and gas utility parent ...

Gilead Sciences on Thursday reported flat second-quarter earnings on slightly higher revenue and raised its full-year ...

The free language-learning app Duolingo grew by nearly a third in value during Thursday's stock trading after its ...

With the "Grand Theft Auto 6" release date no longer in question, exactly how much is this game going to cost?

Data Center Load Agreements -- 580 megawatts of data center load under signed electric service agreements at the electric ...

2025 Non-GAAP Guidance: Initiated 2025 non-GAAP guidance at $3.53–$3.65 per share, contingent upon the outcome of the Montana ...

New EnerSys president and chief executive officer, Shawn O’Connell, wasted little time putting his stamp on the company.

Consensus projections indicate a significant improvement in the company’s performance for this quarter. Analysts anticipate ...